134 related articles for article (PubMed ID: 29733656)
21. [RNPC1 induces sensitivity of HER-2-positive breast cancer BT474 cells to trastuzumab through upregulation of HER2].
Li CL; Zhou XJ; Lou PP; Xia TS; Shi L; Wang Y; Ding Q
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):172-8. PubMed ID: 26988821
[TBL] [Abstract][Full Text] [Related]
22. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.
Zhang M; Xu E; Zhang J; Chen X
Oncogene; 2015 Nov; 34(48):5900-11. PubMed ID: 25823026
[TBL] [Abstract][Full Text] [Related]
23. StarD13: a potential star target for tumor therapeutics.
Jaafar L; Chamseddine Z; El-Sibai M
Hum Cell; 2020 Jul; 33(3):437-443. PubMed ID: 32274657
[TBL] [Abstract][Full Text] [Related]
24. RNA-binding protein SAMD4A inhibits breast tumor angiogenesis by modulating the balance of angiogenesis program.
Zhou M; Wang B; Li H; Han J; Li A; Lu W
Cancer Sci; 2021 Sep; 112(9):3835-3845. PubMed ID: 34219323
[TBL] [Abstract][Full Text] [Related]
25. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
26. The RNA-binding protein RNPC1 stabilizes the mRNA encoding the RNA-binding protein HuR and cooperates with HuR to suppress cell proliferation.
Cho SJ; Jung YS; Zhang J; Chen X
J Biol Chem; 2012 Apr; 287(18):14535-44. PubMed ID: 22371495
[TBL] [Abstract][Full Text] [Related]
27. MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability.
Xu E; Zhang J; Chen X
Oncogene; 2013 Apr; 32(17):2169-78. PubMed ID: 22710720
[TBL] [Abstract][Full Text] [Related]
28. Radiation sensitivity of esophageal adenocarcinoma: the contribution of the RNA-binding protein RNPC1 and p21-mediated cell cycle arrest to radioresistance.
Hötte GJ; Linam-Lennon N; Reynolds JV; Maher SG
Radiat Res; 2012 Mar; 177(3):272-9. PubMed ID: 22214381
[TBL] [Abstract][Full Text] [Related]
29. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
[TBL] [Abstract][Full Text] [Related]
30. RNA Binding Protein RNPC1 Suppresses the Stemness of Human Endometrial Cancer Cells via Stabilizing MST1/2 mRNA.
Wu X; Wang Y; Zhong W; Cheng H; Tian Z
Med Sci Monit; 2020 Feb; 26():e921389. PubMed ID: 32088727
[TBL] [Abstract][Full Text] [Related]
31. Effect of StarD13 on colorectal cancer proliferation, motility and invasion.
Nasrallah A; Saykali B; Al Dimassi S; Khoury N; Hanna S; El-Sibai M
Oncol Rep; 2014 Jan; 31(1):505-15. PubMed ID: 24253896
[TBL] [Abstract][Full Text] [Related]
32. RNA-Binding Protein Dnd1 Promotes Breast Cancer Apoptosis by Stabilizing the Bim mRNA in a miR-221 Binding Site.
Cheng F; Pan Y; Lu YM; Zhu L; Chen S
Biomed Res Int; 2017; 2017():9596152. PubMed ID: 28191469
[TBL] [Abstract][Full Text] [Related]
33. Integrative genomic analyses of the RNA-binding protein, RNPC1, and its potential role in cancer prediction.
Ding Z; Yang HW; Xia TS; Wang B; Ding Q
Int J Mol Med; 2015 Aug; 36(2):473-84. PubMed ID: 26046131
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
35. LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
Jiang Z; Slater CM; Zhou Y; Devarajan K; Ruth KJ; Li Y; Cai KQ; Daly M; Chen X
Breast Cancer Res; 2017 May; 19(1):62. PubMed ID: 28558830
[TBL] [Abstract][Full Text] [Related]
36. PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer.
Li RK; Gao J; Guo LH; Huang GQ; Luo WH
Cancer Gene Ther; 2017 Jul; 24(7):309-315. PubMed ID: 28731027
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
38. Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas.
Zhang J; Cho SJ; Shu L; Yan W; Guerrero T; Kent M; Skorupski K; Chen H; Chen X
Genes Dev; 2011 Jul; 25(14):1528-43. PubMed ID: 21764855
[TBL] [Abstract][Full Text] [Related]
39. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
Kong Q; Qiu M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
